EDUCATION

Undergraduate Degree

  • Massachusetts College of Pharmacy and Health Science , Boston , MA

Graduate Degree

  • Massachusetts College of Pharmacy and Health Science , Boston , MA

Philosophy of Care

It was during a trip to the college fair that a career in pharmacy was first introduced to me. Over time I got more involved in science and medicine and even planned on going to medical school; however, I became drawn to pediatric pharmacy practice, nutrition support in particular. I like the challenges of trying to optimize a child's medication regimen which may mean stopping meds or creating something from scratch. I now have a 36+ year career in pediatric pharmacy and it's been one of the best decisions I've ever made.

PROFESSIONAL HISTORY

Dr. Kathleen Gura is a native New Englander and attended the Massachusetts College of Pharmacy and Health Sciences for both her BS and PharmD degrees. She graduated both programs with high honors.

Upon graduation, Dr. Gura went to Washington, DC for 2 years to work as a clinical pharmacist at Children's National Medical Center. It was there she learned her nutrition basics. She returned to Boston in 1984 and joined the pharmacy staff at BCH. During this time, she also completed a fellowship in clinical nutrition at the University of Florida and became one of the first board certified nutrition support pharmacists in Boston. She has been a member of the Clinical Nutrition program since 1986 and CAIR since its inception.

Today, Dr. Gura is an active member of the American Society for Parenteral and Enteral Nutrition (ASPEN), the American Society for Health System Pharmacists (ASHP) and the Pediatric Pharmacy Advocacy Group (PPAG). She was awarded the ASHP Drug Therapy Research Award as well as the Outstanding Pharmacist and Serlick Award for Safe Practices by ASPEN. Her research focuses on PN associated liver disease, intestinal failure, and lipid emulsions. Her work has been funded by the March of Dimes and the FDA's Orphan Drug Development Program.

CERTIFICATIONS

  • Board of Pharmacy Specialties, Nutrition Support Pharmacist

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Anez-Bustillos L, Dao DT, Potemkin AK, Perez-Atayde AR, Raphael BP, Carey AN, Kamin DS, Thiagarajah J, Crowley M, Gura KM, Puder M. An Intravenous Fish Oil Based Lipid Emulsion successfully treats intractable pruritus and cholestasis in a patient with MVID. Hepatology. 2018 Oct 12. View abstract
  2. Gura KM, Crowley M. A detailed guide to lipid therapy in intestinal failure. Semin Pediatr Surg. 2018 Aug; 27(4):242-255. View abstract
  3. Carey AN, Rudie C, Mitchell PD, Raphael BP, Gura KM, Puder M. Essential Fatty Acid Status in Surgical Infants Receiving Parenteral Nutrition With a Composite Lipid Emulsion: A Case Series. JPEN J Parenter Enteral Nutr. 2018 May 30. View abstract
  4. Raphael BP, Jorina M, Gallotto M, Grullon G, Dalton M, Takvorian-Bené M, Tascione C, Rosa C, McClelland J, Gray M, Potemkin AK, Glavin C, Gura KM, Murphy MK, Leger K, Mahoney J, Kerr J, Ozonoff A, Duggan CP. Innovative Discharge Process for Families with Pediatric Short Bowel Syndrome: A Prospective Nonrandomized Trial. JPEN J Parenter Enteral Nutr. 2018 Nov; 42(8):1295-1303. View abstract
  5. Guenter P, Worthington P, Ayers P, Boullata JI, Gura KM, Marshall N, Holcombe B, Richardson DS. Standardized Competencies for Parenteral Nutrition Administration: The ASPEN Model. Nutr Clin Pract. 2018 Apr; 33(2):295-304. View abstract
  6. Baker MA, Nandivada P, Mitchell PD, Fell GL, Pan A, Anez-Bustillos L, Dao DT, Gura KM, Nosé V, Puder M. Pretreatment with intravenous fish oil reduces hepatic ischemia reperfusion injury in a murine model. Surgery. 2018 05; 163(5):1035-1039. View abstract
  7. Gura KM, Mulberg AE, Mitchell PD, Yap J, Kim CY, Chen M, Potemkin A, Puder M. Pediatric Intestinal Failure-Associated Liver Disease: Challenges in Identifying Clinically Relevant Biomarkers. JPEN J Parenter Enteral Nutr. 2018 Feb; 42(2):455-462. View abstract
  8. Baker MA, Mitchell PD, O'Loughlin AA, Potemkin AK, Anez-Bustillos L, Dao DT, Fell GL, Gura KM, Puder M. Characterization of Fatty Acid Profiles in Infants With Intestinal Failure-Associated Liver Disease. JPEN J Parenter Enteral Nutr. 2018 Jan; 42(1):71-77. View abstract
  9. Dao DT, Anez-Bustillos L, Cho BS, Li Z, Puder M, Gura KM. Assessment of Micronutrient Status in Critically Ill Children: Challenges and Opportunities. Nutrients. 2017 Oct 28; 9(11). View abstract
  10. Karwowski MP, Stamoulis C, Wenren LM, Faboyede GM, Quinn N, Gura KM, Bellinger DC, Woolf AD. Blood and Hair Aluminum Levels, Vaccine History, and Early Infant Development: A Cross-Sectional Study. Acad Pediatr. 2018 Mar; 18(2):161-165. View abstract
  11. Murphy MK, Gura KM, Tascione C, Carey AN, Duggan CP, Raphael BP. Home Parenteral Nutrition and Intravenous Fluid Errors Discovered Through Novel Clinical Practice of Reconciling Compounding Records: A Case Series. Nutr Clin Pract. 2017 Dec; 32(6):820-825. View abstract
  12. Christensen ML, Ayers P, Boullata JI, Guenter P, Gura KM, Holcombe B, Seres DS, Sacks GS. Lipid Injectable Emulsion Survey With Gap Analysis. Nutr Clin Pract. 2017 Oct; 32(5):694-702. View abstract
  13. Anez-Bustillos L, Dao DT, Fell GL, Baker MA, Gura KM, Bistrian BR, Puder M. Redefining essential fatty acids in the era of novel intravenous lipid emulsions. Clin Nutr. 2018 Jun; 37(3):784-789. View abstract
  14. Fell GL, Gura KM, Puder M. Response to Driscoll. JPEN J Parenter Enteral Nutr. 2017 07; 41(5):704-705. View abstract
  15. Guenter P, Ayers P, Boullata JI, Gura KM, Holcombe B, Sacks GS. Parenteral Nutrition Errors and Potential Errors Reported Over the Past 10 Years. Nutr Clin Pract. 2017 Dec; 32(6):826-830. View abstract
  16. Martin CR, Stoll B, Cluette-Brown J, Akinkuotu AC, Olutoye OO, Gura KM, Singh P, Zaman MM, Perillo MC, Puder M, Freedman SD, Burrin D. Use of a novel docosahexaenoic acid formulation vs control in a neonatal porcine model of short bowel syndrome leads to greater intestinal absorption and higher systemic levels of DHA. Nutr Res. 2017 Mar; 39:51-60. View abstract
  17. Nandivada P, Fell GL, Pan AH, Nose V, Mitchell PD, Gura KM, Puder M. Parenteral Soybean Oil Induces Hepatosteatosis Despite Addition of Fish Oil in a Mouse Model of Intestinal Failure-Associated Liver Disease. JPEN J Parenter Enteral Nutr. 2017 Feb 01; 148607117695249. View abstract
  18. Martinez EE, Pereira LM, Gura K, Stenquist N, Ariagno K, Nurko S, Mehta NM. Gastric Emptying in Critically Ill Children. JPEN J Parenter Enteral Nutr. 2017 09; 41(7):1100-1109. View abstract
  19. Fell GL, O'Loughlin AA, Nandivada P, Potemkin AK, Mitchell PD, Mahoney J, Gura KM, Puder M. Methods to Reduce Medication Errors in a Clinical Trial of an Investigational Parenteral Medication. Contemp Clin Trials Commun. 2016 Dec 15; 4:64-67. View abstract
  20. Nandivada P, Anez-Bustillos L, O'Loughlin AA, Mitchell PD, Baker MA, Dao DT, Fell GL, Potemkin AK, Gura KM, Neufeld EJ, Puder M. Risk of post-procedural bleeding in children on intravenous fish oil. Am J Surg. 2017 Oct; 214(4):733-737. View abstract
  21. Gura KM, Mulberg AE, Mitchell PD, Yap J, Kim CY, Chen M, Potemkin A, Puder M. Pediatric Intestinal Failure-Associated Liver Disease: Challenges in Identifying Clinically Relevant Biomarkers. JPEN J Parenter Enteral Nutr. 2016 Sep 28. View abstract
  22. Anez-Bustillos L, Dao DT, Baker MA, Fell GL, Puder M, Gura KM. Intravenous Fat Emulsion Formulations for the Adult and Pediatric Patient: Understanding the Differences. Nutr Clin Pract. 2016 Oct; 31(5):596-609. View abstract
  23. Nandivada P, Baker MA, Mitchell PD, O'Loughlin AA, Potemkin AK, Anez-Bustillos L, Carlson SJ, Dao DT, Fell GL, Gura KM, Puder M. Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children. Am J Clin Nutr. 2016 09; 104(3):663-70. View abstract
  24. Riedy M, DePaula B, Puder M, Gura KM, Sztam KA. Higher Doses of Fish Oil-Based Lipid Emulsions Used to Treat Inadequate Weight Gain and Rising Triene:Tetraene Ratio in a Severely Malnourished Infant With Intestinal Failure-Associated Liver Disease. JPEN J Parenter Enteral Nutr. 2017 05; 41(4):667-671. View abstract
  25. Fell GL, Cho BS, Pan A, Nose V, Anez-Bustillos L, Dao DT, Baker MA, Nandivada P, Gura KM, Puder M. A Comparison of Fish Oil Sources for Parenteral Lipid Emulsions in a Murine Model. JPEN J Parenter Enteral Nutr. 2017 02; 41(2):181-187. View abstract
  26. Raphael BP, Murphy M, Gura KM, Litman H, Dalton MK, Finkelstein JA, Lightdale JR. Discrepancies Between Prescribed and Actual Pediatric Home Parenteral Nutrition Solutions. Nutr Clin Pract. 2016 Oct; 31(5):654-8. View abstract
  27. Nandivada P, Fell GL, Mitchell PD, Potemkin AK, O'Loughlin AA, Gura KM, Puder M. Long-Term Fish Oil Lipid Emulsion Use in Children With Intestinal Failure-Associated Liver Disease [Formula: see text]. JPEN J Parenter Enteral Nutr. 2017 08; 41(6):930-937. View abstract
  28. Nandivada P, Fell GL, Gura KM, Puder M. Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children. Am J Clin Nutr. 2016 Feb; 103(2):629S-34S. View abstract
  29. Young LS, Huong PT, Lam NT, Thu NN, Van HT, Hanh NL, Tuyen le D, Lien DT, Hoc TH, Tuyet CT, Anh NQ, Henry EG, Lenders CM, Gura KM, Bigornia SJ, Apovian CM, Ziegler TR. Nutritional status and feeding practices in gastrointestinal surgery patients at Bach Mai Hospital, Hanoi, Vietnam. Asia Pac J Clin Nutr. 2016; 25(3):513-20. View abstract
  30. Fell GL, Nandivada P, Gura KM, Puder M. Intravenous Lipid Emulsions in Parenteral Nutrition. Adv Nutr. 2015 Sep; 6(5):600-10. View abstract
  31. Plogsted S, Cober P, Gura KM, Helms RA, Robinson D. Parenteral Nutrition L-Cysteine Product Shortage Considerations. Nutr Clin Pract. 2015 Aug; 30(4):579-80. View abstract
  32. Bechard LJ, Gordon C, Feldman HA, Venick R, Gura K, Guinan EC, Duggan C. Bone loss and vitamin D deficiency in children undergoing hematopoietic cell transplantation. Pediatr Blood Cancer. 2015 Apr; 62(4):687-92. View abstract
  33. Chang MI, Carlson SJ, Nandivada P, O'Loughlin AA, Potemkin AK, Cowan E, Mitchell PD, Gura KM, Puder M. Challenging the 48-Hour Rule-Out for Central Line-Associated Bloodstream Infections in the Pediatric Intestinal Failure Population: A Retrospective Pilot Study. JPEN J Parenter Enteral Nutr. 2016 05; 40(4):567-73. View abstract
  34. Nandivada P, Chang MI, Potemkin AK, Carlson SJ, Cowan E, O'loughlin AA, Mitchell PD, Gura KM, Puder M. The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy. Ann Surg. 2015 Jan; 261(1):172-9. View abstract
  35. Vanek VW, Seidner DL, Allen P, Bistrian B, Collier S, Gura K, Miles JM, Valentine CJ. Update to A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2014 Dec; 29(6):841. View abstract
  36. Gura KM. Aluminum contamination in parenteral products. Curr Opin Clin Nutr Metab Care. 2014 Nov; 17(6):551-7. View abstract
  37. Carlson SJ, Nandivada P, Chang MI, Mitchell PD, O'Loughlin A, Cowan E, Gura KM, Nose V, Bistrian BR, Puder M. The addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice. Metabolism. 2015 Feb; 64(2):274-82. View abstract
  38. Nandivada P, Potemkin AK, Carlson SJ, Chang MI, Cowan E, O'Loughlin AA, Gura KM, Puder M. Elevated Alkaline Phosphatase in Infants With Parenteral Nutrition-Associated Liver Disease Reflects Bone Rather Than Liver Disease. JPEN J Parenter Enteral Nutr. 2015 Nov; 39(8):973-6. View abstract
  39. Moniz TT, Chu S, Tom C, Lutz P, Arnold A, Gura KM, Patterson A. Sterile product compounding using an i.v. compounding workflow management system at a pediatric hospital. Am J Health Syst Pharm. 2014 Aug 01; 71(15):1311-7. View abstract
  40. Fallon EM, Mitchell PD, Nehra D, Potemkin AK, O'Loughlin AA, Gura KM, Puder M. Neonates with short bowel syndrome: an optimistic future for parenteral nutrition independence. JAMA Surg. 2014 Jul; 149(7):663-70. View abstract
  41. Gosselin KB, Feldman HA, Sonis AL, Bechard LJ, Kellogg MD, Gura K, Venick R, Gordon CM, Guinan EC, Duggan C. Serum citrulline as a biomarker of gastrointestinal function during hematopoietic cell transplantation in children. J Pediatr Gastroenterol Nutr. 2014 Jun; 58(6):709-14. View abstract
  42. Miller J, Dalton MK, Duggan C, Lam S, Iglesias J, Jaksic T, Gura KM. Going with the flow or swimming against the tide: should children with central venous catheters swim? Nutr Clin Pract. 2014 Feb; 29(1):97-109. View abstract
  43. Nandivada P, Carlson SJ, Chang MI, Cowan E, Gura KM, Puder M. Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions. Adv Nutr. 2013 Nov; 4(6):711-7. View abstract
  44. Kalish BT, Le HD, Fitzgerald JM, Wang S, Seamon K, Gura KM, Gronert K, Puder M. Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory proresolving lipid mediators. Am J Physiol Gastrointest Liver Physiol. 2013 Dec; 305(11):G818-28. View abstract
  45. Díaz JJ, Gura KM, Roda J, Perez-Atayde AR, Duggan C, Jaksic T, Lo CW. Aspartate aminotransferase to platelet ratio index correlates with hepatic cirrhosis but not with fibrosis in pediatric patients with intestinal failure. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):367-71. View abstract
  46. Nandivada P, Carlson SJ, Cowan E, Chang MI, Gura KM, Puder M. Role of parenteral lipid emulsions in the preterm infant. Early Hum Dev. 2013 Oct; 89 Suppl 2:S45-9. View abstract
  47. Vanek VW, Allen P, Harvey Banchik LP, Bistrian B, Collier S, Driscoll DF, Gura K, Houston DR, Miles J, Mirtallo J, Mogensen KM, Seidner D. Parenteral nutrition intravenous fat emulsions product shortage considerations. Nutr Clin Pract. 2013 Aug; 28(4):528-9. View abstract
  48. Nehra D, Fallon EM, Potemkin AK, Voss SD, Mitchell PD, Valim C, Belfort MB, Bellinger DC, Duggan C, Gura KM, Puder M. A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial. JPEN J Parenter Enteral Nutr. 2014 Aug; 38(6):693-701. View abstract
  49. Nehra D, Carlson SJ, Fallon EM, Kalish B, Potemkin AK, Gura KM, Simpser E, Compher C, Puder M. A.S.P.E.N. clinical guidelines: nutrition support of neonatal patients at risk for metabolic bone disease. JPEN J Parenter Enteral Nutr. 2013 Sep; 37(5):570-98. View abstract
  50. Nandivada P, Cowan E, Carlson SJ, Chang M, Gura KM, Puder M. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease. Prostaglandins Leukot Essent Fatty Acids. 2013 Sep; 89(4):153-8. View abstract
  51. Kalish BT, Le HD, Gura KM, Bistrian BR, Puder M. A metabolomic analysis of two intravenous lipid emulsions in a murine model. PLoS One. 2013; 8(4):e59653. View abstract
  52. Chang MI, Puder M, Gura KM. The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD). Nutrients. 2012 Nov 27; 4(12):1828-50. View abstract
  53. Carlson SJ, Fallon EM, Kalish BT, Gura KM, Puder M. The role of the ?-3 fatty acid DHA in the human life cycle. JPEN J Parenter Enteral Nutr. 2013 Jan; 37(1):15-22. View abstract
  54. Fallon EM, Nehra D, Potemkin AK, Gura KM, Simpser E, Puder M, Compher C. Response to Meyer and Gortner. JPEN J Parenter Enteral Nutr. 2013 Jan; 37(1):13-4. View abstract
  55. Le HD, Fallon EM, Kalish BT, de Meijer VE, Meisel JA, Gura KM, Nose V, Pan AH, Bistrian BR, Puder M. The effect of varying ratios of docosahexaenoic acid and arachidonic acid in the prevention and reversal of biochemical essential fatty acid deficiency in a murine model. Metabolism. 2013 Apr; 62(4):499-508. View abstract
  56. Fallon EM, Nehra D, Potemkin AK, Gura KM, Simpser E, Puder M, Compher C. Response to the letter to the editor regarding Nutrition support of neonatal patients at risk for necrotizing enterocolitis. JPEN J Parenter Enteral Nutr. 2013 Jan; 37(1):12. View abstract
  57. Nehra D, Fallon EM, Carlson SJ, Potemkin AK, Hevelone ND, Mitchell PD, Gura KM, Puder M. Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates. JPEN J Parenter Enteral Nutr. 2013 Jul; 37(4):498-505. View abstract
  58. Fallon EM, Nehra D, Potemkin AK, Gura KM, Simpser E, Compher C, Puder M. A.S.P.E.N. clinical guidelines: nutrition support of neonatal patients at risk for necrotizing enterocolitis. JPEN J Parenter Enteral Nutr. 2012 Sep; 36(5):506-23. View abstract
  59. Vanek VW, Seidner DL, Allen P, Bistrian B, Collier S, Gura K, Miles JM, Valentine CJ, Kochevar M. A.S.P.E.N. position paper: Clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2012 Apr; 27(2):150-92. View abstract
  60. Bechard LJ, Feldman HA, Venick R, Gura K, Gordon C, Sonis A, Mehta N, Guinan EC, Duggan C. Attenuation of resting energy expenditure following hematopoietic SCT in children. Bone Marrow Transplant. 2012 Oct; 47(10):1301-6. View abstract
  61. Sharma TS, Bechard LJ, Feldman HA, Venick R, Gura K, Gordon CM, Sonis A, Guinan EC, Duggan C. Effect of titrated parenteral nutrition on body composition after allogeneic hematopoietic stem cell transplantation in children: a double-blind, randomized, multicenter trial. Am J Clin Nutr. 2012 Feb; 95(2):342-51. View abstract
  62. Arsenault D, Brenn M, Kim S, Gura K, Compher C, Simpser E, Puder M. A.S.P.E.N. Clinical Guidelines: hyperglycemia and hypoglycemia in the neonate receiving parenteral nutrition. JPEN J Parenter Enteral Nutr. 2012 Jan; 36(1):81-95. View abstract
  63. Fuchs J, Fallon EM, Gura KM, Puder M. Use of an omega-3 fatty acid-based emulsion in the treatment of parenteral nutrition-induced cholestasis in patients with microvillous inclusion disease. J Pediatr Surg. 2011 Dec; 46(12):2376-82. View abstract
  64. Le HD, Meisel JA, de Meijer VE, Fallon EM, Gura KM, Nose V, Bistrian BR, Puder M. Docosahexaenoic acid and arachidonic acid prevent essential fatty acid deficiency and hepatic steatosis. JPEN J Parenter Enteral Nutr. 2012 Jul; 36(4):431-41. View abstract
  65. Le HD, de Meijer VE, Robinson EM, Zurakowski D, Potemkin AK, Arsenault DA, Fallon EM, Malkan A, Bistrian BR, Gura KM, Puder M. Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children. Am J Clin Nutr. 2011 Sep; 94(3):749-58. View abstract
  66. Meisel JA, Le HD, de Meijer VE, Nose V, Gura KM, Mulkern RV, Sharif MRA, Puder M. Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. J Pediatr Surg. 2011 Apr; 46(4):666-673. View abstract
  67. Le HD, de Meijer VE, Zurakowski D, Meisel JA, Gura KM, Puder M. Parenteral fish oil as monotherapy improves lipid profiles in children with parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr. 2010 Sep-Oct; 34(5):477-84. View abstract
  68. Gura KM, Puder M. Rapid infusion of fish oil-based emulsion in infants does not appear to be associated with fat overload syndrome. Nutr Clin Pract. 2010 Aug; 25(4):399-402. View abstract
  69. Le HD, Gura KM, Arsenault DA, Fallon EM, Potemkin AK, Puder M. Assessing portal fibrosis in parenteral nutrition-dependent patients treated with omega-3 fatty acid lipid emulsion. J Pediatr. 2010 Sep; 157(3):517; author reply 518. View abstract
  70. de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease. Arch Surg. 2010 Jun; 145(6):547-51. View abstract
  71. Jones BA, Hull MA, Richardson DS, Zurakowski D, Gura K, Fitzgibbons SC, Duro D, Lo CW, Duggan C, Jaksic T. Efficacy of ethanol locks in reducing central venous catheter infections in pediatric patients with intestinal failure. J Pediatr Surg. 2010 Jun; 45(6):1287-93. View abstract
  72. Gura KM. Aluminum contamination in products used in parenteral nutrition: has anything changed? Nutrition. 2010 Jun; 26(6):585-94. View abstract
  73. Le HD, Fallon EM, de Meijer VE, Malkan AD, Puder M, Gura KM. Innovative parenteral and enteral nutrition therapy for intestinal failure. Semin Pediatr Surg. 2010 Feb; 19(1):27-34. View abstract
  74. de Meijer VE, Le HD, Meisel JA, Gura KM, Puder M. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr. 2010 Feb; 50(2):212-8. View abstract
  75. Ling PR, Andersson C, Strijbosch R, Lee S, Silvestri A, Gura KM, Puder M, Bistrian BR. Effects of glucose or fat calories in total parenteral nutrition on fat metabolism and systemic inflammation in rats. Metabolism. 2011 Feb; 60(2):195-205. View abstract
  76. de Meijer VE, Gura KM, Puder M. Parenteral nutrition in the critically ill patient. N Engl J Med. 2010 Jan 07; 362(1):81-2; author reply 83-4. View abstract
  77. Bechard LJ, Feldman HA, Gordon C, Gura K, Sonis A, Leung K, Venick R, Guinan EC, Duggan C. A multi-center, randomized, controlled trial of parenteral nutrition titrated to resting energy expenditure in children undergoing hematopoietic stem cell transplantation ("PNTREE"): rationale and design. Contemp Clin Trials. 2010 Mar; 31(2):157-64. View abstract
  78. Lee SI, Valim C, Johnston P, Le HD, Meisel J, Arsenault DA, Gura KM, Puder M. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res. 2009 Dec; 66(6):698-703. View abstract
  79. Gura KM. Is there still a role for peripheral parenteral nutrition? Nutr Clin Pract. 2009 Dec; 24(6):709-17. View abstract
  80. Puder M, Valim C, Meisel JA, Le HD, de Meijer VE, Robinson EM, Zhou J, Duggan C, Gura KM. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009 Sep; 250(3):395-402. View abstract
  81. de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr. 2009 Sep-Oct; 33(5):541-7. View abstract
  82. Le HD, Meisel JA, de Meijer VE, Gura KM, Puder M. The essentiality of arachidonic acid and docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep; 81(2-3):165-70. View abstract
  83. de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M. Parenteral fish oil as monotherapy for patients with parenteral nutrition-associated liver disease. Pediatr Surg Int. 2009 Jan; 25(1):123-4. View abstract
  84. Strijbosch RA, Lee S, Arsenault DA, Andersson C, Gura KM, Bistrian BR, Puder M. Fish oil prevents essential fatty acid deficiency and enhances growth: clinical and biochemical implications. Metabolism. 2008 May; 57(5):698-707. View abstract
  85. Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, Arsenault DA, Strijbosch RA, Lopes S, Duggan C, Puder M. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008 Mar; 121(3):e678-86. View abstract
  86. Lee S, Gura KM, Puder M. Re: Influence of different intravenous lipid emulsions on hepatobiliary dysfunction in a rabbit model. J Pediatr Gastroenterol Nutr. 2008 Feb; 46(2):224-5; author reply 225. View abstract
  87. Gura K, Strijbosch R, Arnold S, McPherson C, Puder M. The role of an intravenous fat emulsion composed of fish oil in a parenteral nutrition-dependent patient with hypertriglyceridemia. Nutr Clin Pract. 2007 Dec; 22(6):664-72. View abstract
  88. Ching YA, Gura K, Modi B, Jaksic T. Pediatric intestinal failure: nutrition, pharmacologic, and surgical approaches. Nutr Clin Pract. 2007 Dec; 22(6):653-63. View abstract
  89. Forchielli ML, Richardson D, Folkman J, Gura K, Lo CW. Better living through chemistry, constant monitoring, and prompt interventions: 26 years on home parenteral nutrition without major complications. Nutrition. 2008 Jan; 24(1):103-7. View abstract
  90. Lee S, Gura KM, Puder M. Omega-3 fatty acids and liver disease. Hepatology. 2007 Apr; 45(4):841-5. View abstract
  91. Lee S, Gura KM, Kim S, Arsenault DA, Bistrian BR, Puder M. Current clinical applications of omega-6 and omega-3 fatty acids. Nutr Clin Pract. 2006 Aug; 21(4):323-41. View abstract
  92. Lee S, Gura KM, Kim S, Arsenault DA, Bistrian BR, Puder M. Current Clinical Applications of O-6 and O-3 Fatty Acids. Nutr Clin Pract. 2006 Aug; 21(4):323-341. View abstract
  93. Alwayn IP, Andersson C, Lee S, Arsenault DA, Bistrian BR, Gura KM, Nose V, Zauscher B, Moses M, Puder M. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. Am J Physiol Gastrointest Liver Physiol. 2006 Dec; 291(6):G1011-9. View abstract
  94. Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, Puder M. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006 Jul; 118(1):e197-201. View abstract
  95. Gura KM, Puder M. Recent developments in aluminium contamination of products used in parenteral nutrition. Curr Opin Clin Nutr Metab Care. 2006 May; 9(3):239-46. View abstract
  96. Kim S, Gura KM, Puder M. Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis. Pediatr Surg Int. 2006 Jun; 22(6):562-4. View abstract
  97. Gura KM, Parsons SK, Bechard LJ, Henderson T, Dorsey M, Phipatanakul W, Duggan C, Puder M, Lenders C. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr. 2005 Oct; 24(5):839-47. View abstract
  98. Javid PJ, Greene AK, Garza J, Gura K, Alwayn IP, Voss S, Nose V, Satchi-Fainaro R, Zausche B, Mulkern RV, Jaksic T, Bistrian B, Folkman J, Puder M. The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. J Pediatr Surg. 2005 Sep; 40(9):1446-53. View abstract
  99. Javid PJ, Collier S, Richardson D, Iglesias J, Gura K, Lo C, Kim HB, Duggan CP, Jaksic T. The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants. J Pediatr Surg. 2005 Jun; 40(6):1015-8. View abstract
  100. Alwayn IP, Andersson C, Zauscher B, Gura K, Nosé V, Puder M. Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor. Transplantation. 2005 Mar 15; 79(5):606-8. View abstract
  101. Alwayn IP, Gura K, Nosé V, Zausche B, Javid P, Garza J, Verbesey J, Voss S, Ollero M, Andersson C, Bistrian B, Folkman J, Puder M. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005 Mar; 57(3):445-52. View abstract
  102. Duggan C, Stark AR, Auestad N, Collier S, Fulhan J, Gura K, Utter S, Teixeira-Pinto A, Donovan K, Lund D. Glutamine supplementation in infants with gastrointestinal disease: a randomized, placebo-controlled pilot trial. Nutrition. 2004 Sep; 20(9):752-6. View abstract
  103. Gura KM. Incidence and nature of epidemic nosocomial infections. J Infus Nurs. 2004 May-Jun; 27(3):175-80. View abstract
  104. Alwayn IP, Javid PJ, Gura KM, Nosé V, Ollero M, Puder M. Do polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREPB-1 suppression or by correcting essential fatty acid deficiency. Hepatology. 2004 Apr; 39(4):1176-7; author reply 1177-8. View abstract
  105. Duggan C, Rizzo C, Cooper A, Klavon S, Fuchs V, Gura K, Richardson D, Collier S, Lo C. Effectiveness of a clinical practice guideline for parenteral nutrition: a 5-year follow-up study in a pediatric teaching hospital. JPEN J Parenter Enteral Nutr. 2002 Nov-Dec; 26(6):377-81. View abstract
  106. Forchielli ML, Gura K, Anessi-Pessina E, Richardson D, Cai W, Lo CW. Success rates and cost-effectiveness of antibiotic combinations for initial treatment of central-venous-line infections during total parenteral nutrition. JPEN J Parenter Enteral Nutr. 2000 Mar-Apr; 24(2):119-25. View abstract
  107. McDermott JS, Gura KM. Procedures for preparing injectable medications for latex-sensitive patients. Am J Health Syst Pharm. 1997 Nov 01; 54(21):2516-7. View abstract
  108. Forchielli ML, Lo CW, Richardson D, Gura K, Walker WA, Tonelli E. Central venous line related bacteremia during total parenteral nutrition and/or chemotherapy infusions in children. Ann Ig. 1997 Jan-Feb; 9(1):35-40. View abstract
  109. Forchielli ML, Gura KM, Sandler R, Lo C. Aminosyn PF or trophamine: which provides more protection from cholestasis associated with total parenteral nutrition? J Pediatr Gastroenterol Nutr. 1995 Nov; 21(4):374-82. View abstract
  110. Gura KM. Parenteral drug administration guidelines for the pediatric patient: one hospital's recommendations. Hosp Pharm. 1993 Mar; 28(3):221-3, 227-8, 231-42. View abstract